STOCK TITAN

Nortech Systems Reports First Quarter Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Nortech Systems (NSYS) reported challenging Q1 2025 financial results with net sales of $26.9 million, down 21.4% year-over-year, and a net loss of $1.3 million ($0.48 per share) compared to net income of $765,000 in Q1 2024. The company's Adjusted EBITDA showed a loss of $1.0 million. The decline was attributed to ongoing facility consolidation efforts and delays in defense customer approvals for production transfers from the closed Blue Earth facility to Bemidji plant. Despite short-term challenges, management highlighted strategic repositioning initiatives, including R&D investments in fiber optic technologies resulting in two new patents. The company maintains a 90-day backlog of $26.7 million as of March 31, 2025, and expects to clear the majority of approval backlogs in Q2 2025.
Nortech Systems (NSYS) ha riportato risultati finanziari difficili nel primo trimestre 2025 con vendite nette di 26,9 milioni di dollari, in calo del 21,4% rispetto all'anno precedente, e una perdita netta di 1,3 milioni di dollari (0,48 dollari per azione) rispetto a un utile netto di 765.000 dollari nel primo trimestre 2024. L'EBITDA rettificato della società ha mostrato una perdita di 1,0 milione di dollari. Il calo è stato attribuito agli sforzi in corso di consolidamento degli impianti e ai ritardi nelle approvazioni da parte dei clienti del settore difesa per i trasferimenti di produzione dalla struttura chiusa di Blue Earth allo stabilimento di Bemidji. Nonostante le difficoltà a breve termine, la direzione ha evidenziato iniziative di riposizionamento strategico, inclusi investimenti in R&S nelle tecnologie a fibra ottica che hanno portato a due nuovi brevetti. La società mantiene un portafoglio ordini di 90 giorni pari a 26,7 milioni di dollari al 31 marzo 2025 e prevede di risolvere la maggior parte dei ritardi nelle approvazioni nel secondo trimestre 2025.
Nortech Systems (NSYS) reportó resultados financieros desafiantes en el primer trimestre de 2025 con ventas netas de 26,9 millones de dólares, una disminución del 21,4% interanual, y una pérdida neta de 1,3 millones de dólares (0,48 dólares por acción) en comparación con una ganancia neta de 765,000 dólares en el primer trimestre de 2024. El EBITDA ajustado de la empresa mostró una pérdida de 1,0 millón de dólares. La caída se atribuyó a los esfuerzos continuos de consolidación de instalaciones y a los retrasos en las aprobaciones de clientes del sector defensa para transferencias de producción desde la planta cerrada de Blue Earth a la planta de Bemidji. A pesar de los desafíos a corto plazo, la dirección destacó iniciativas de reposicionamiento estratégico, incluyendo inversiones en I+D en tecnologías de fibra óptica que resultaron en dos nuevas patentes. La empresa mantiene un respaldo de pedidos a 90 días de 26,7 millones de dólares al 31 de marzo de 2025 y espera despejar la mayoría de los retrasos en aprobaciones en el segundo trimestre de 2025.
Nortech Systems(NSYS)는 2025년 1분기에 순매출 2,690만 달러로 전년 동기 대비 21.4% 감소한 어려운 실적을 보고했으며, 순손실 130만 달러(주당 0.48달러)를 기록하여 2024년 1분기 순이익 76만 5천 달러와 대비된다. 회사의 조정 EBITDA는 100만 달러 손실을 보였다. 이러한 감소는 시설 통합 노력 지속과 폐쇄된 Blue Earth 시설에서 Bemidji 공장으로의 생산 이전에 대한 방위산업 고객 승인 지연에 기인한다. 단기적인 어려움에도 불구하고 경영진은 두 건의 신규 특허를 포함한 광섬유 기술 연구개발 투자 등 전략적 재배치 이니셔티브를 강조했다. 회사는 2025년 3월 31일 기준 90일 주문 잔고 2,670만 달러를 유지하고 있으며, 2025년 2분기 내 대부분의 승인 지연을 해소할 것으로 기대하고 있다.
Nortech Systems (NSYS) a publié des résultats financiers difficiles pour le premier trimestre 2025 avec des ventes nettes de 26,9 millions de dollars, en baisse de 21,4 % d'une année sur l'autre, et une perte nette de 1,3 million de dollars (0,48 dollar par action) contre un bénéfice net de 765 000 dollars au premier trimestre 2024. L'EBITDA ajusté de la société a affiché une perte d'un million de dollars. Ce déclin a été attribué aux efforts continus de consolidation des installations et aux retards dans les approbations des clients du secteur de la défense pour les transferts de production de l'usine fermée de Blue Earth vers l'usine de Bemidji. Malgré ces défis à court terme, la direction a souligné des initiatives de repositionnement stratégique, notamment des investissements en R&D dans les technologies à fibre optique, aboutissant à deux nouveaux brevets. La société maintient un carnet de commandes de 90 jours de 26,7 millions de dollars au 31 mars 2025 et prévoit de lever la majorité des retards d'approbation au deuxième trimestre 2025.
Nortech Systems (NSYS) meldete herausfordernde Finanzergebnisse für das erste Quartal 2025 mit Nettoverkäufen von 26,9 Millionen US-Dollar, was einem Rückgang von 21,4 % im Jahresvergleich entspricht, und einem Nettoverlust von 1,3 Millionen US-Dollar (0,48 US-Dollar pro Aktie) im Vergleich zu einem Nettogewinn von 765.000 US-Dollar im ersten Quartal 2024. Das bereinigte EBITDA des Unternehmens wies einen Verlust von 1,0 Million US-Dollar auf. Der Rückgang wurde auf laufende Konsolidierungsmaßnahmen der Anlagen und Verzögerungen bei den Genehmigungen von Verteidigungskunden für Produktionsverlagerungen von der geschlossenen Blue Earth-Anlage zur Bemidji-Anlage zurückgeführt. Trotz kurzfristiger Herausforderungen hob das Management strategische Neuausrichtungsinitiativen hervor, darunter F&E-Investitionen in faseroptische Technologien, die zu zwei neuen Patenten führten. Das Unternehmen hält zum 31. März 2025 einen Auftragsbestand von 26,7 Millionen US-Dollar für 90 Tage und erwartet, den Großteil der Genehmigungsverzögerungen im zweiten Quartal 2025 zu beseitigen.
Positive
  • Two new patents issued in fiber optic technologies in the past year
  • Strategic consolidation to improve efficiency and reduce cost structure
  • Well-positioned for near-shoring opportunities in response to customer supply chain needs
  • Maintained solid backlog of $26.7 million
Negative
  • Net sales decreased 21.4% year-over-year to $26.9 million
  • Reported net loss of $1.3 million compared to $765,000 profit last year
  • Gross profit declined 43.5% year-over-year
  • Operating expenses increased 9.3% despite lower sales
  • Delays in defense customers' approvals for facility transfers

Insights

Nortech reported significant declines across all financial metrics, with restructuring efforts still underway amid challenging operational transitions.

Nortech Systems' Q1 2025 results reveal substantial financial deterioration compared to the same period last year. Revenue dropped 21.4% to $26.9 million, while the company swung from a $765,000 profit to a $1.3 million loss. This represents a staggering 272% negative swing in profitability.

The financial deterioration extends across all key metrics. Gross profit plummeted 43.5% to $3.1 million, indicating severe margin compression. Meanwhile, operating expenses increased 9.3% to $4.7 million, creating a dangerous cost structure imbalance. Adjusted EBITDA, a crucial measure of operational performance, shifted from a positive $1.6 million to a negative $1 million – a 161.1% decline.

Management attributes these disappointing results to production transfers from their closed Blue Earth facility to their Bemidji plant, which have been delayed due to pending defense customer approvals. They expect to clear this approval backlog in Q2 2025, which may provide some operational relief.

The company's 90-day backlog stands at $26.7 million, almost equivalent to their quarterly revenue, suggesting potential stabilization in the near term if they can successfully navigate their operational transitions. Their balance sheet shows $1.2 million in cash and increased borrowing on their credit line, rising from $8.6 million to $12 million during the quarter.

Notably, Nortech recorded $266,000 in restructuring charges, reflecting ongoing efforts to consolidate operations and reposition the business. Management's statements suggest they're sacrificing short-term performance for long-term strategic positioning, particularly in aerospace & defense and medical imaging markets.

MINNEAPOLIS, May 14, 2025 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial and aerospace & defense markets, reported financial results for the first quarter ended March 31, 2025.

2025 Q1 Highlights:

 Net sales of $26.9 million
 Net loss of ($1.3) million, or ($0.48) per diluted share
 Adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”) of ($1.0) million loss
 90-day backlog of $26.7 million as of March 31, 2025
   

Management Commentary

“Over the past few quarters, we have successfully transitioned and stabilized our business, allowing for smoother operational flow and setting a solid foundation for future growth. Nortech has taken steps to consolidate our operations to focus on driving profitability and growth within our core market segments. These strategic moves are designed to better scale the business, improve efficiency, and reduce our ongoing cost structure.” said Jay D. Miller, President and CEO. “We made tough decisions that have depressed our short-term revenues and EBITDA but have strategically positioned the Company for long-term growth and innovation specifically in the aerospace & defense and medical imaging markets.”

“The Company experienced delays in our defense customers’ approvals for transfers from our closed Blue Earth facility to our Bemidji plant, and those transfers continue to progress steadily. We continue to anticipate clearing the majority of this approval backlog during the second quarter of 2025. Additionally, our research and development programs, particularly in fiber optic technologies, reflect our commitment to provide customers with technologies that are lighter, faster and more sustainable. This commitment has been evident by the issuance of two new patents in the past year,” Miller added.

“We continue to be impressed by the dedication and collaboration demonstrated by our employees across all locations to do the hard work necessary to achieve our goals. The team’s unwavering commitment enables us to overcome challenges and embrace innovation,” Miller said.

“We’re also closely following changes in regulations, trade policies, and geopolitical factors for potential impacts in our key market segments. We believe the strategic repositioning of our global operations in the past year has further strengthened the Company’s ability to respond to our customers’ needs to near-shore their supply chains. We are well-prepared to shift production closer to key markets, improving efficiency and strengthening our ability to handle global challenges and uncertainties.”

Summary Financial Information

The following table provides summary financial information comparing the first quarter 2025 (“Q1 2025”) financial results to the same quarter in 2024 (“Q1 2024”).

($ in thousands) Q1 2025  Q1 2024  % Change 
Net sales $26,895  $34,215   (21.4)%
Gross profit $3,078  $5,448   (43.5)%
Operating expenses $4,691  $4,293   9.3%
Net (loss) income $(1,316) $765   (272.0)%
EBITDA $(1,266) $1,637   (177.3)%
Adjusted EBITDA $(1,000) $1,637   (161.1)%
             

Conference Call

The Company will hold a live conference call and webcast at 3:30 p.m. central time on Wednesday, May 14, to discuss the Company’s 2025 first quarter results. The call will be hosted by Jay D. Miller, Chief Executive Officer and President and Andrew D. C. LaFrence, Chief Financial Officer. To access the live audio conference call, US participants may call 888-506-0062 and international participants may call 973-528-0011. Participant Access Code: 830813. Participants may also access the call via webcast at: https://www.webcaster4.com/Webcast/Page/2814/52260.

###

About Nortech Systems Incorporated

Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech primarily serves the medical imaging, medical device, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire, cable, and interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has six manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 including without limitation statements regarding future financial results, gaining approval of customers relating to moving production from one facility to another Company-owned facility, strengthening of customer relationships, achieving long-term strategic goals, effects of restructuring and consolidating manufacturing facilities, sustained long-term health and growth, ability to scale our business, reducing cost structure and optimism about customer pipeline. While this release is based on management’s best judgment and current expectations, actual results may differ materially from those expressed or implied and involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation: (1) commodity cost increases coupled with challenges in raising prices and/or customer pressure to reduce prices; (2) supply chain disruptions leading to shortages of critical components; (3) volatility in market conditions which may affect demand for the Company’s products; (4) increased competition and/or reduced demand; (5) changes in the reliability and efficiency of operating facilities or those of third parties; (6) risks related to the availability of labor; (7) the unanticipated loss of any key member of senior management; (8) geopolitical, economic, financial and business conditions; (9) the Company’s ability to steadily improve manufacturing output and product quality; (10) the impact of global health epidemics on our customers, employees, manufacturing facilities, suppliers, the capital markets and our financial condition; or (11) challenges with customers with respect to moving production from one facility to another Company-owned facility. Some of the above-mentioned factors are described in further detail in the section entitled “Risk Factors” in our annual and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the date hereof, or as otherwise specified, as our business, financial condition, results of operations and prospects may have changed since such date. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, to reflect actual results or changes in factors or assumptions affecting such forward-looking statements.

Reconciliation of Generally Accepted Accounting Principles (“GAAP”) Measures to Non-GAAP Financial Measure

EBITDA is a non-GAAP financial measure used by management that we believe provides useful information to investors because it reflects ongoing performance excluding certain non-recurring items during comparable periods and facilitates comparisons between peer companies since interest, taxes, depreciation, and amortization can differ greatly between different organizations as a result of differing capital structures and tax strategies. EBITDA is defined as net income (loss) plus interest expense, plus income tax expense plus depreciation expense and amortization expense. EBITDA should be considered in addition to, not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Adjusted EBITDA reflects the impact of restructuring and non-recurring items. EBITDA and Adjusted EBITDA are not a measurement of our financial performance under GAAP and should not be considered an alternative to net sales or net income (loss), as applicable, or any other performance measures derived in accordance with GAAP and may not be comparable to other similarly titled measures of other businesses. EBITDA and Adjusted EBITDA have limitations as an analytical metric, and you should not consider it in isolation or as a substitute for analysis of our operating results as reported under GAAP.

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE (LOSS) INCOME
(UNAUDITED)
(IN THOUSANDS, EXCEPT SHARE DATA)

  THREE MONTHS ENDED 
  MARCH 31, 
  2025  2024 
       
Net sales $26,895  $34,215 
Cost of goods sold  23,817   28,767 
Gross profit  3,078   5,448 
Operating expenses        
Selling  1,184   805 
General and administrative  2,915   3,170 
Research and development  326   318 
Restructuring charges  266   - 
Total operating expenses  4,691   4,293 
(Loss) income from operations  (1,613)  1,155 
Other expense        
Interest expense  (214)  (167)
(Loss) income before income taxes  (1,827)  988 
Income tax (benefit) expense  (511)  223 
Net (loss) income $(1,316) $765 
         
Net (loss) income per common share:        
Basic (in dollars per share) $(0.48) $0.28 
Weighted average number of common shares outstanding - basic (in shares)  2,760,929   2,742,511 
Diluted (in dollars per share) $(0.48) $0.26 
Weighted average number of common shares outstanding - diluted (in shares)  2,760,929   2,908,457 
         
Other comprehensive (loss) income        
Foreign currency translation  6   (183)
Comprehensive (loss) income, net of tax $(1,310) $582 


NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF MARCH 31, 2025 AND DECEMBER 31, 2024
(UNAUDITED)
(IN THOUSANDS, EXCEPT SHARE DATA)

  MARCH 31, 2025  DECEMBER 31, 2024 
ASSETS        
Current assets:        
Cash $1,162  $916 
Accounts receivable, less allowances of $231 and $196, respectively  15,668   14,875 
Inventories, net  20,910   21,638 
Contract assets  13,404   13,792 
Assets held for sale  507   - 
Prepaid assets and other assets  5,673   4,094 
Total current assets  57,324   55,315 
Property and equipment, net  5,575   6,232 
Operating lease assets, net  7,831   8,139 
Deferred tax assets  2,575   2,575 
Other intangible assets, net  169   174 
Other assets  59   - 
Total assets $73,533  $72,435 
         
LIABILITIES AND SHAREHOLDERS’ EQUITY        
Current liabilities:        
Accounts payable $10,062  $11,582 
Accrued payroll and commissions  2,515   1,841 
Customer deposits  5,028   5,140 
Current portion of operating leases  1,187   1,175 
Current portion of finance lease obligations  121   143 
Notes payable  563   344 
Other accrued liabilities  1,240   1,203 
Total current liabilities  20,716   21,428 
Long-term liabilities:        
Long-term line of credit  11,955   8,634 
Long-term operating lease obligations, net of current portion  7,462   7,773 
Long-term finance lease obligations, net of current portion  281   311 
Other long-term liabilities  287   284 
Total long-term liabilities  19,985   17,002 
Total liabilities  40,701   38,430 
Shareholders’ equity:        
Preferred stock, $1 par value; 1,000,000 shares authorized; 250,000 shares issued and outstanding  250   250 
Common stock - $0.01 par value; 9,000,000 shares authorized; 2,760,993 and 2,760,793 shares issued and outstanding, respectively  28   28 
Additional paid-in capital  17,466   17,329 
Accumulated other comprehensive loss  (971)  (977)
Retained earnings  16,059   17,375 
Total shareholders’ equity  32,832   34,005 
Total liabilities and shareholders’ equity $73,533  $72,435 


NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(IN THOUSANDS)

  THREE MONTHS ENDED
MARCH 31,
 
  2025  2024 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net (loss) income $(1,316) $765 
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:        
Depreciation  342   442 
Amortization  5   40 
Compensation on stock-based awards  118   80 
Change in accounts receivable allowances  35   (66)
Change in inventory reserves  231   76 
Other, net  -   (4)
Changes in current operating assets and liabilities:        
Accounts receivable  (814)  3,215 
Inventories  487   (1,400)
Contract assets  388   287 
Prepaid expenses and other assets  (1,588)  (328)
Accounts payable  (1,441)  (8)
Accrued payroll and commissions  674   640 
Customer deposits  (112)  (926)
Other accrued liabilities  61   15 
Net cash (used in) provided by operating activities  (2,930)  2,828 
         
CASH FLOWS FROM INVESTING ACTIVITIES        
Proceeds from sale of property and equipment  -   9 
Purchases of property and equipment  (268)  (744)
Net cash used in investing activities  (268)  (735)
         
CASH FLOWS FROM FINANCING ACTIVITIES        
Proceeds from line of credit  25,970   32,768 
Payments to line of credit  (22,710)  (32,394)
Proceeds from notes payable  219   - 
Principal payments on financing leases  (52)  (100)
Stock option exercises  19   - 
Net cash provided by financing activities  3,446   274 
         
Effect of exchange rate changes on cash  (2)  (14)
         
Net change in cash  246   2,353 
Cash - beginning of period  916   1,675 
Cash - end of period $1,162  $4,028 


  THREE MONTHS ENDED
MARCH 31,
 
  2025  2024 
RECONCILIATION OF NET (LOSS) INCOME TO EBITDA        
($ in thousands)        
Net (loss) income $(1,316) $765 
Interest  214   167 
Taxes  (511)  223 
Depreciation  342   442 
Amortization  5   40 
EBITDA  (1,266)  1,637 
Restructuring charges  266   - 
ADJUSTED EBITDA $(1,000) $1,637 


There were no material adjustments to EBITDA in the quarter ended March 31, 2024.

Adjustment to EBITDA in the quarter ended March 31, 2025 includes ($ in thousands):

 In the second quarter of 2024, we announced the closure of our Blue Earth, Minnesota facility. In connection with activities related to the Blue Earth facility and additional staff reductions in the first quarter of 2025, we incurred $266 of restructuring charges in the quarter ended March 31, 2025, which expense amount is not included in Adjusted EBITDA.


($ in millions) Last Twelve Months (LTM) Ended in Quarter 
  Q1 2022  Q2 2022  Q3 2022  Q4 2022  Q1 2023  Q2 2023  Q3 2023  Q4 2023  Q1 2024  Q2 2024  Q3 2024  Q4 2024  Q1 2025 
Net Sales $123.8  $126.1  $132.0  $134.1  $138.3  $140.8  $138.9  $139.3  $138.7  $137.5  $135.6  $128.1  $120.8 
                                                     
Gross Profit $ - Adjusted  13.7   15.1   18.1   20.5   21.9   22.4   21.4   23.1   23.1   22.2   20.7   16.7   14.4 
Gross Margin % - Adjusted  11.0%  12.0%  13.7%  15.3%  15.8%  15.9%  15.4%  16.6%  16.6%  16.1%  14.9%  13.1%  11.9%
                                                     
EBITDA - Adjusted $1.9  $2.5  $4.2  $5.8  $6.7  $6.8  $6.0  $8.0  $8.1  $7.3  $5.9  $2.1  $(0.5)
                                                     

Contact

Andrew D. C. LaFrence
Chief Financial Officer and Senior Vice President of Finance
alafrence@nortechsys.com
952-345-2243


FAQ

What were Nortech Systems (NSYS) Q1 2025 earnings results?

Nortech reported a net loss of $1.3 million ($0.48 per share) on revenue of $26.9 million, compared to net income of $765,000 on revenue of $34.2 million in Q1 2024.

Why did Nortech Systems (NSYS) revenue decline in Q1 2025?

The revenue decline was primarily due to facility consolidation efforts and delays in defense customer approvals for production transfers from the closed Blue Earth facility to the Bemidji plant.

What is Nortech Systems' (NSYS) current backlog as of Q1 2025?

Nortech Systems reported a 90-day backlog of $26.7 million as of March 31, 2025.

What strategic initiatives is Nortech Systems (NSYS) implementing?

Nortech is consolidating operations, investing in R&D for fiber optic technologies (securing two new patents), and repositioning global operations to support near-shoring of customer supply chains.

When does Nortech Systems (NSYS) expect to resolve its facility transfer delays?

The company expects to clear the majority of the approval backlog during the second quarter of 2025.
Nortech Sys Inc

NASDAQ:NSYS

NSYS Rankings

NSYS Latest News

NSYS Latest SEC Filings

NSYS Stock Data

23.65M
932.00k
65.09%
4.85%
0.15%
Medical Devices
Electronic Components, Nec
Link
United States
MAPLE GROVE